vericiguat

CHEBI:CHEBI_142432

Definition

A pyrazolopyridine that is 5-fluoro-1H-pyrazolo[3,4-b]pyridine in which the amino hydrogen at position 1 has been substituted by a 2-fluorobenzyl group and the hydrogen at position 3 has been substituted by a 4,6-diamino-5-[(methoxycarbonyl)amino]pyrimidin-2-yl group. It is a soluble guanylate cyclase stimulator which is used for treatment of chronic heart failure.

Chemical Information

Molecular Formula
C19H16F2N8O2
Molecular Mass
426.380
Charge
0
SMILES
N=1C(=NC(=C(C1N)NC(=O)OC)N)C=2C3=C(N(N2)CC=4C(=CC=CC4)F)N=CC(=C3)F
InChI
InChI=1S/C19H16F2N8O2/c1-31-19(30)25-14-15(22)26-17(27-16(14)23)13-11-6-10(20)7-24-18(11)29(28-13)8-9-4-2-3-5-12(9)21/h2-7H,8H2,1H3,(H,25,30)(H4,22,23,26,27)
InChIKey
QZFHIXARHDBPBY-UHFFFAOYSA-N

Alternative Names

  • BAY-1021189
  • BAY1021189
  • methyl {4,6-diamino-2-[5-fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}carbamate
  • methyl N-[4,6-diamino-2-[5-fluoro-1-[(2-fluorophenyl)methyl]pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl]carbamate
  • MK-1242
  • vericiguat
  • vericiguatum

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

DRON_00010000
2475830
oboInOwl#hasDbXref
Reaxys:22098890
core#notation
CHEBI:142432

Additional References

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

oboInOwl#hasOBONamespace
chebi_ontology
DRON_00010000
2475830
oboInOwl#hasDbXref
Reaxys:22098890
oboInOwl#id
CHEBI:142432
generic_name
Vericiguat
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20251231
route
ORAL
dosage_form
POWDER
marketing_start_date
20210119
package_marketing_start_date
19-JAN-21
labeler_name
MSN Life Sciences Private Limited
manufacturer_name
Merck Sharp & Dohme LLC
brand_name
VERQUVO
brand_name_base
VERQUVO
product_ndc
68554-0164
application_number
NDA214377
spl_id
1b3cf1f8-f262-8541-e063-6394a90a4358
package_ndc
68554-0164-1
package_description
1 kg in 1 DRUM (68554-0164-1)
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_76022
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
core#notation
CHEBI:142432
rxcui
2475860
active_ingredient_strength
1 kg/kg
active_ingredient_name
VERICIGUAT
unii
LV66ADM269
spl_set_id
17056d73-1b1b-4bf2-9c07-b7a9367f0d6d
nui
N0000190485
upc
0300065028026
pharm_class_epc
Soluble Guanylate Cyclase Stimulator [EPC]
pharm_class
Guanylate Cyclase Stimulators [MoA]
pharm_class_moa
Guanylate Cyclase Stimulators [MoA]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect5283
owl#annotatedSource
t112572
owl#someValuesFrom
t3745410